RecruitingNCT05361603
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities "Outside the Walls" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan
Sponsor
University Hospital, Limoges
Enrollment
1,500 participants
Start Date
May 24, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Adult 18 and over
- Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector
- Patient who agreed to participate to the research
Exclusion Criteria1
- Patient doesn't agree to participate to the research
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05361603
Related Trials
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT012808251 location
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
NCT0539042411 locations
The Hepatitis C Transplant Collaborative
NCT044933851 location
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT0703727789 locations
Evaluation of Patients With Liver Disease
NCT000019711 location